GSK Investigational Site

Colchester CO3 3NB

0 studies enrolling now · 2 studies all time

What they study most

Melanoma, Thrombocytopaenia

Studies at this site

• A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor — Stopped early
• SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy — Completed